Silencing of EZH2 sensitized the lung cancer cells to gefitinib and induced expression of p16 and p21, suggesting that HOTAIR contributes to gefitinib resistance by regulating EZH2/p16/p21 axis (Li et al., 2021). The gene discussed is EZH2; the disease is lung carcinoma.